BenevolentAI was last valued at $2B (pre-money). It comes from the $115M Series C of Apr 2018. The company is private, so there is no listed share price.
1 valuation. The latest, $2B pre-money, was set by the Series C in Apr 2018.
A private valuation is the price agreed in one transaction. The BenevolentAI valuation of $2B is a pre-money figure from the Series C dated 1 Apr 2018 .
The valuation holds until the next priced round or secondary sale. A private company founded in 2014 has no daily price and no order book between rounds.
No. BenevolentAI is a private company; its shares do not trade on a public exchange.
The last valuation is $2B.
Lead investors for each round are in the funding timeline.
The closest biotechnology/ai peers are on the competitors page.
Perpetual markets for stocks, gold, indices and pre-IPO names — settled on-chain, no wallet-to-exchange transfers.
